Details for New Drug Application (NDA): 021505
✉ Email this page to a colleague
The generic ingredient in KEPPRA is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 021505
Tradename: | KEPPRA |
Applicant: | Ucb Inc |
Ingredient: | levetiracetam |
Patents: | 0 |
Pharmacology for NDA: 021505
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 021505
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
KEPPRA | levetiracetam | SOLUTION;ORAL | 021505 | NDA | UCB, Inc. | 50474-001 | 50474-001-48 | 473 mL in 1 BOTTLE, PLASTIC (50474-001-48) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 100MG/ML | ||||
Approval Date: | Jul 15, 2003 | TE: | AA | RLD: | Yes |
Expired US Patents for NDA 021505
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ucb Inc | KEPPRA | levetiracetam | SOLUTION;ORAL | 021505-001 | Jul 15, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Ucb Inc | KEPPRA | levetiracetam | SOLUTION;ORAL | 021505-001 | Jul 15, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription